Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation.
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation.
复制标题
DOI:
10.1371/journal.pbio.2004663
复制
发表时间:
2018-06
期刊:
影响因子:
9.8
通讯作者:
Robbins PD
中科院分区:
文献类型:
--
作者:
Zhao J;Zhang L;Mu X;Doebelin C;Nguyen W;Wallace C;Reay DP;McGowan SJ;Corbo L;Clemens PR;Wilson GM;Watkins SC;Solt LA;Cameron MD;Huard J;Niedernhofer LJ;Kamenecka TM;Robbins PD
Nuclear factor κB (NF-κB) is a transcription factor important for regulating innate and adaptive immunity, cellular proliferation, apoptosis, and senescence. Dysregulation of NF-κB and its upstream regulator IκB kinase (IKK) contributes to the pathogenesis of multiple inflammatory and degenerative diseases as well as cancer. An 11–amino acid peptide containing the NF-κB essential modulator (NEMO)-binding domain (NBD) derived from the C-terminus of β subunit of IKK, functions as a highly selective inhibitor of the IKK complex by disrupting the association of IKKβ and the IKKγ subunit NEMO. A structure-based pharmacophore model was developed to identify NBD mimetics by in silico screening. Two optimized lead NBD mimetics, SR12343 and SR12460, inhibited tumor necrosis factor α (TNF-α)- and lipopolysaccharide (LPS)-induced NF-κB activation by blocking the interaction between IKKβ and NEMO and suppressed LPS-induced acute pulmonary inflammation in mice. Chronic treatment of a mouse model of Duchenne muscular dystrophy (DMD) with SR12343 and SR12460 attenuated inflammatory infiltration, necrosis and muscle degeneration, demonstrating that these small-molecule NBD mimetics are potential therapeutics for inflammatory and degenerative diseases. Aberrant up-regulation of the transcription factor nuclear factor κB (NF-κB) and the IκB kinase (IKK) that regulates NF-κB is associated with a variety of inflammatory and degenerative diseases in humans, including aging. Thus, development of effective and specific drugs able to decrease IKK/NF-κB activity has significant therapeutic potential. In this study, a structure-derived computational approach was used to screen for small-molecule inhibitors of the protein–protein interaction between the IKKß and IKKγ subunits of the IKK complex. We identified and developed a novel class of small molecules that selectively inhibit IKK/NF-κB activation by dissociating the IKK complex without affecting c-Jun N-terminal kinase (JNK)/p38-mitogen-activated protein kinase (MAPK) signaling. These novel molecules reduce lipopolysaccharide (LPS)-induced acute inflammation in mice and improve muscle pathology in the mdx mouse model of Duchenne muscular dystrophy (DMD), suggesting that they would have potential clinical utility.
登录
查看更多内容
影响因子:
15
作者:
Golden, Mary S.;Cote, Shaun M.;Sayeg, Marianna;Zerbe, Brandon S.;Villar, Elizabeth A.;Beglov, Dmitri;Sazinsky, Stephen L.;Georgiadis, Rosina M.;Vajda, Sandor;Kozakov, Dima;Whitty, Adrian
通讯作者:
Whitty, Adrian
DOI:
10.1074/jbc.m109.099895
发表时间:
2010-04-30
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Baima ET;Guzova JA;Mathialagan S;Nagiec EE;Hardy MM;Song LR;Bonar SL;Weinberg RA;Selness SR;Woodard SS;Chrencik J;Hood WF;Schindler JF;Kishore N;Mbalaviele G
通讯作者:
Mbalaviele G
影响因子:
8.2
作者:
Oguiza, Ainhoa;Recio, Carlota;Gomez-Guerrero, Carmen
通讯作者:
Gomez-Guerrero, Carmen
影响因子:
15.9
作者:
Tilstra, Jeremy S.;Robinson, Andria R.;Robbins, Paul D.
通讯作者:
Robbins, Paul D.
影响因子:
3.5
作者:
Jain, AN
通讯作者:
Jain, AN